24th November 2021 | Pharma Updates
FDA approves Alembic's Formoterol Fumarate Inhalation Solution
The solution is indicated to patients with COPD and bronchitis problems.
Asia’s largest capsules-making unit and research hub to come up in Maharashtra
The facility will be established at a cost of around Rs 600 cr.
Delays in US FDA foreign inspections a growing concern
US trading partners are raising concerns about the US FDA’s continued delays in inspecting international drug manufacturing facilities due to the Covid and travel restrictions.
SII seeks Govt to Fast track Covishield Movement
Institute has cited its problem in cold storage facilities and productions of other vaccines.
Zydus submits NDA to DCGI for Desidustat
“With innovative approaches, we want to improve the quality of life of patients and with Desidustat we have taken yet another step in this direction, ” said, Pankaj R. Patel, Chairman, Cadila Healthcare Ltd.
Aimil Pharma targets business of 750 cr INR
Aimil Pharmaceuticals is aiming to enter the international markets in the first quarter of 2022.
India's pharma must address the problem of antimicrobial resistance
More than 30% of neonatal sepsis deaths in India are attributed to antimicrobial resistance.